Screener
Collegium Pharmaceutical, Inc. COLL Nucynta Products — Cost
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | June 30, 2026 / Cost | June 30, 2026 / Accumulated Amortization | June 30, 2026 / Carrying Amount | December 31, 2025 / Cost | December 31, 2025 / Accumulated Amortization | December 31, 2025 / Carrying Amount |
|---|---|---|---|---|---|---|
| Jornay PM | $635,000 | $(152,986) | $482,014 | $635,000 | $(111,072) | $523,928 |
| Azstarys | 635,000 | (7,480) | 627,520 | — | — | — |
| Belbuca | 360,000 | (322,305) | 37,695 | 360,000 | (284,607) | 75,393 |
| Nucynta Products | 521,170 | (521,170) | — | 521,170 | (493,478) | 27,692 |
| Symproic | 70,000 | (31,145) | 38,855 | 70,000 | (27,503) | 42,497 |
| Total intangible assets | $2,221,170 | $(1,035,086) | $1,186,084 | $1,586,170 | $(916,660) | $669,510 |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s nucynta products — cost?
- Collegium Pharmaceutical, Inc. (COLL) reported nucynta products — cost of $521.17M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s nucynta products — cost changed year-over-year?
- Collegium Pharmaceutical, Inc.'s nucynta products — cost decreased by 0.0% year-over-year, from $521.17M to $521.17M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s nucynta products — cost?
- Over 3 years (2022 to 2025), Collegium Pharmaceutical, Inc.'s nucynta products — cost has grown at a 0.0% compound annual growth rate (CAGR), from $2.08B to $2.08B.
- What does nucynta products — cost mean?
- Represents the total direct and indirect costs associated with the production, distribution, and support of the Nucynta product line. This metric is essential for evaluating the gross margin and overall profitability of the specific pharmaceutical product segment.
Ask your AI about Collegium Pharmaceutical, Inc.'s nucynta products — cost.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude